Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 16/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | ITK | Q08881 | 5/20 | 0.43 |
| ▸ | AXL | P30530 | 1/20 | 0.42 |
| ▸ | BTK | Q06187 | 5/20 | 0.41 |
| ▸ | BCL6 | P41182 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1740268 | 0.93 | PRKCQ (0.45) | EGFRPRKCQITKBTKBCL6 | |
| SCHEMBL1741140 | 0.91 | EGFR (0.49) | EGFRITKAXLBTKBCL6 | |
| SCHEMBL1742617 | 0.90 | EGFR (0.45) | EGFRPRKCQITKBTK | |
| SCHEMBL1740982 | 0.90 | PRKCQ (0.49) | EGFRPRKCQITKAXLBTK | |
| SCHEMBL1741034 | 0.89 | EGFR (0.48) | EGFRPRKCQITKAXLBTK | |
| SCHEMBL1740749 | 0.88 | EGFR (0.49) | EGFRPRKCQITKAXLBTK | |
| SCHEMBL1739951 | 0.87 | PRKCQ (0.47) | EGFRPRKCQITKBTK | |
| SCHEMBL3504657 | 0.86 | PRKCQ (0.48) | EGFRPRKCQITKAXLBTK | |
| SCHEMBL3504889 | 0.86 | EGFR (0.52) | EGFRPRKCQITKBTK | |
| SCHEMBL3507872 | 0.86 | PRKCQ (0.49) | EGFRPRKCQITKAXLBTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2389373-A1 | DERIVATIVES OF N2-(3-PYRIDIL OR PHENYL)-N4-(4-PIPERIDYL)-2,4-PYRIMIDINEDIAMINE USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE OR PROLIFERATIVE DISEASES | Rigel Pharmaceuticals, Inc. (US) | 2011-11-30 | — | — | EP | claimed |
| US-20110253835-A1 | AIRCRAFT INTERIOR LAVATORY | BE INTELLECTUAL PROPERTY, INC. (US) | 2011-10-20 | — | — | US | claimed |
| WO-2010090875-A1 | DERIVATIVES OF N2-(3-PYRIDIL OR PHENYL)-N4-(4-PIPERIDYL)-2,4-PYRIMIDINEDIAMINE USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE OR PROLIFERATIVE DISEASES | RIGEL PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | WO | claimed |
| EP-2389373-A1 | DERIVATIVES OF N2-(3-PYRIDIL OR PHENYL)-N4-(4-PIPERIDYL)-2,4-PYRIMIDINEDIAMINE USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE OR PROLIFERATIVE DISEASES | Rigel Pharmaceuticals, Inc. (US) | 2011-11-30 | — | — | EP | disclosed |
| US-20110253835-A1 | AIRCRAFT INTERIOR LAVATORY | BE INTELLECTUAL PROPERTY, INC. (US) | 2011-10-20 | — | — | US | disclosed |
| WO-2010090875-A1 | DERIVATIVES OF N2-(3-PYRIDIL OR PHENYL)-N4-(4-PIPERIDYL)-2,4-PYRIMIDINEDIAMINE USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE OR PROLIFERATIVE DISEASES | RIGEL PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | WO | disclosed |